OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Gastroenterology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020	200
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020	156
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020	109
Evidence-based clinical practice guidelines for peptic ulcer disease 2020	85
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021	72
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020	70
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments	67
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis	61
Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial	57
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retros	45
Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up	45
Evidence-based clinical practice guidelines for management of colorectal polyps	45
Evidence-based clinical practice guidelines for functional dyspepsia 2021	44
Efficacy of endoscopic ultrasound with artificial intelligence for the diagnosis of gastrointestinal stromal tumors	43
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019	42
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan	41
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia	41
Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study	41
Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants	39
COVID-19-associated liver injury: from bedside to bench	37
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020	34
Real-time assessment of video images for esophageal squamous cell carcinoma invasion depth using artificial intelligence	33
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study	33
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study	32
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy	30

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan	30
Lactobacillus stress protein GroEL prevents colonic inflammation	29
Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases	28